Impact of endotoxin on the expression of drug transporters in the placenta of HIV‐1 transgenic (HIV‐Tg) rats

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejps.2017.03.004PMID 28274777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory Markers Related to Microbial Translocation Among HIV-Infected Pregnant Women: A Risk Factor of Preterm Delivery.

  2016cited by this paper
• Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats

  2016cited by this paper
• Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition

  2015cited by this paper
• Maternal bacterial infections impact expression of drug transporters in human placenta.

  2015cited by this paper
• Polyinosinic/Polycytidylic Acid–Mediated Changes in Maternal and Fetal Disposition of Lopinavir in Rats

  2015cited by this paper
• Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

  2015cited by this paper
• Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model.

  2014cited by this paper
• Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

  2014cited by this paper
• HIV-1 Transgenic Rats Display Alterations in Immunophenotype and Cellular Responses Associated with Aging

  2014cited by this paper
• Expression of Membrane Drug Efflux Transporters in the Sigmoid Colon of HIV‐Infected and Uninfected Men

  2013cited by this paper
• ENT1, a Ribavirin Transporter, Plays a Pivotal Role in Antiviral Efficacy of Ribavirin in a Hepatitis C Virus Replication Cell System

  2012cited by this paper
• OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

  2012cited by this paper
• Microbial translocation in HIV infection: causes, consequences and treatment opportunities

  2012cited by this paper
• Expression of ABC Efflux Transporters in Placenta from Women with Insulin-Managed Diabetes

  2012cited by this paper
• Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 U.S. Preventive Services Task Force Recommendation

  2012cited by this paper
• Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients

  2012cited by this paper
• ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy Condition

  2011cited by this paper
• HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS.

  2011cited by this paper
• Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.

  2011cited by this paper
• Endotoxemia Is Associated with Altered Innate and Adaptive Immune Responses in Untreated HIV-1 Infected Individuals

  2011cited by this paper
• Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

  2011cited by this paper
• Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid)

  2011cited by this paper
• Regulation of P‐glycoprotein by human immunodeficiency virus‐1 in primary cultures of human fetal astrocytes

  2011cited by this paper
• Characterization of ribavirin uptake systems in human hepatocytes.

  2010cited by this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cited by this paper
• Innate immune recognition and activation during HIV infection

  2010cited by this paper
• The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART.

  2010cited by this paper
• Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy.

  2009cited by this paper
• HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers

  2009cited by this paper
• HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection

  2009cited by this paper
• Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

  2009cited by this paper
• Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

  2009cited by this paper
• LPS/TLR4 signal transduction pathway.

  2008cited by this paper
• HIV‐1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein‐1 (Mrp1) in glial cells

  2008cited by this paper
• Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

  2008cited by this paper
• Immune activation and inflammation in HIV‐1 infection: causes and consequences

  2008cited by this paper
• Effect of Endotoxin on the Expression of Placental Drug Transporters and Glyburide Disposition in Pregnant Rats

  2008cited by this paper
• Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006

  2008cited by this paper
• Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection

  2008cited by this paper
• Immunodeficient Parameters in the HIV-1 Transgenic Rat Model

  2007cited by this paper
• Drug transport across the placenta, role of the ABC drug efflux transporters

  2007cited by this paper
• Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta

  2007cited by this paper
• Expression of the Mu Opioid Receptor in the Human Immunodeficiency Virus Type 1 Transgenic Rat Model

  2007cited by this paper
• Independent Regulation of Apical and Basolateral Drug Transporter Expression and Function in Placental Trophoblasts by Cytokines, Steroids, and Growth Factors

  2007cited by this paper
• Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery

  2006cited by this paper
• Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection

  2006cited by this paper
• HIV-1 Viral Envelope Glycoprotein gp120 Triggers an Inflammatory Response in Cultured Rat Astrocytes and Regulates the Functional Expression of P-Glycoprotein

  2006cited by this paper
• HIV disease: fallout from a mucosal catastrophe?

  2006cited by this paper
• Functional role of P‐glycoprotein in the human blood‐placental barrier

  2005cited by this paper
• HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.

  2005cited by this paper
• Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging.

  2005cited by this paper
• Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.

  2004cited by this paper
• Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties

  2004cited by this paper
• The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum

  2004cited by this paper
• Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

  2004cited by this paper
• Steroid hormone synthesis in pregnancy.

  2004cited by this paper
• Examination of the Functional Activity of P-glycoprotein in the Rat Placental Barrier Using Rhodamine 123

  2003cited by this paper
• HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection

  2003cited by this paper
• Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to reduce Perinatal HIV-1Transmission in the United States

  2003cited by this paper
• Macrophage activation through CCR5‐ and CXCR4‐mediated gp120‐elicited signaling pathways

  2003cited by this paper
• Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

  2002cited by this paper
• Combination Antiretroviral Strategies for the Treatment of Pregnant HIV‐1‐Infected Women and Prevention of Perinatal HIV‐1 Transmission

  2002cited by this paper
• Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta.

  2002cited by this paper
• Mother-to-infant transmission of HIV-1: the placenta fights back.

  2001cited by this paper
• An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction

  2001cited by this paper
• Short Communication: Expression of P-Glycoprotein and Multidrug Resistance-Associated Protein in Healthy Volunteers and HIV-Infected Patients

  2001cited by this paper
• Expression of P-glycoprotein and multidrug resistance-associated protein in healthy volunteers and HIV-infected patients.

  2001cited by this paper
• Identification of Thyroid Hormone Transporters in Humans: Different Molecules Are Involved in a Tissue-Specific Manner*,†.

  2001cited by this paper
• Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.

  2000cited by this paper
• Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

  2000cited by this paper
• Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production.

  1999cited by this paper
• In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus-infected subjects.

  1999cited by this paper
• Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.

  1999cited by this paper
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper
• P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity.

  1997cited by this paper

• Linking TLR-7 Signaling to Downregulation of Placental P-Glycoprotein: Implications for Fetal Drug Exposure

  2025cites this paper
• Impacts of prenatal environmental exposures on fetal-placental-maternal bile acid homeostasis and long-term health in offspring.

  2024cites this paper
• Special Section on Mechanistic and Translational Research on Transporters in Toxicology — Minireview Regulation of Placental Efflux Transporters during Pregnancy Complications

  2022cites this paper
• Pharmacokinetics in pregnancy

  2022cites this paper
• Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta

  2022cites this paper
• Managing Cancer Drug Resistance from the Perspective of Inflammation

  2022cites this paper
• Regulation of Placental Efflux Transporters during Pregnancy Complications

  2022cites this paper
• Impact of Th-17 Cytokines on the Regulation of Transporters in Human Placental Explants

  2021cites this paper
• Role of HIV and Antiretroviral Therapy on the Expression of Placental Transporters in Women with HIV

  2020cites this paper
• Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia

  2020cites this paper
• Contributions of Drug Transporters to Blood-Placental Barrier.

  2019cites this paper